Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Most legal cases about 5α-reductase inhibitors, drugs for hair loss and prostate issues, complain about side effects and delayed cancer diagnosis, with most lawsuits settled out of court.

Long-term data and a team approach are needed to manage chronic side effects from cancer treatments.

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.

5α-reductase inhibitors do not improve survival in oesophageal and gastric cancer patients.

Some drugs used to treat inflammation may cause hair loss.

Finasteride, a drug that prevents testosterone conversion, can effectively reduce blood loss in prostate surgery, especially for patients with a prostatic volume over 30 cc, and decrease post-surgery complications.

Interferon α‐2b can temporarily reduce hepatitis C virus and normalize liver enzyme levels.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Tofacitinib helped regrow hair in a patient with severe hair loss and improved their quality of life without side effects.

Upadacitinib may effectively treat resistant lichen planopilaris.

Tyrosine kinase inhibitors effectively treat cancers but often cause skin and other side effects.

Dutasteride is more effective than finasteride for treating BPH without extra safety risks.

Infliximab can trigger lupus-like symptoms in Crohn's disease patients.

JAK inhibitors effectively regrow hair in alopecia areata but hair loss often returns after stopping treatment.

Taking finasteride for benign prostate hyperplasia may increase the risk of osteoporosis, especially at higher doses.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Baricitinib is effective for Alopecia Areata but requires careful patient history evaluation.

Upadacitinib helps most people with alopecia regrow hair quickly and is generally safe.

Atorvastatin may cause hair loss in some people.

Combination therapy with fesoterodine and doxazosin improves bladder function and delays BPH progression.

Aromatase inhibitors can cause skin issues, especially with anastrozole and exemestane, so monitoring is important.

5 alpha-reductase inhibitors, like finasteride, are used to treat conditions like prostate issues and skin disorders.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.

Tofacitinib effectively treated both ulcerative colitis and alopecia areata in two patients.

Ritlecitinib significantly regrows scalp hair in people with alopecia areata.

Calcineurin inhibitors, used in kidney transplants, can cause a wide range of side effects including kidney damage and other health issues.

Baricitinib improved platelet counts and alopecia in a 16-year-old with chronic immune thrombocytopenia.

Finasteride may help prevent prostate cancer.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.